| Authors: |
Feiten AF; Metabolic Biochemistry, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Dahm K; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany., Schlepckow K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., van Lengerich B; Denali Therapeutics, Inc., South San Francisco, California, 94080, USA., Suh JH; Denali Therapeutics, Inc., South San Francisco, California, 94080, USA., Reifschneider A; Metabolic Biochemistry, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Munich, Germany., Wefers B; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Bartos LM; Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians Universität München, Munich, Germany., Wind-Mark K; Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians Universität München, Munich, Germany., de Weerd L; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Ulas T; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics at the German Center for Neurodegenerative Diseases (DZNE), University of Bonn, Western German Genome Center (WGGC), Bonn, Germany., De-Domenico E; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics at the German Center for Neurodegenerative Diseases (DZNE), University of Bonn, Western German Genome Center (WGGC), Bonn, Germany., Grundschöttel P; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics at the German Center for Neurodegenerative Diseases (DZNE), University of Bonn, Western German Genome Center (WGGC), Bonn, Germany., Paulusch S; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics at the German Center for Neurodegenerative Diseases (DZNE), University of Bonn, Western German Genome Center (WGGC), Bonn, Germany., Tast B; Biomedical Center, Faculty of Medicine, Core Facility Flow Cytometry, Ludwig-Maximilians Universität München, Munich, Germany., Honda T; Biomedical Center, Faculty of Medicine, Core Facility Flow Cytometry, Ludwig-Maximilians Universität München, Munich, Germany., Müller SA; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine and Health, TUM University Hospital, Technical University of Munich (TUM), Munich, Germany., Becker M; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Modular High-Performance Computing and Artificial Intelligence, Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany., Khalin I; Institute for Stroke and Dementia Research,, University Hospital, Ludwig-Maximilians Universität München, Munich, Germany.; Normandie University, UNICAEN, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France., Ricci A; Institute for Stroke and Dementia Research,, University Hospital, Ludwig-Maximilians Universität München, Munich, Germany., Liesz A; Institute for Stroke and Dementia Research,, University Hospital, Ludwig-Maximilians Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Brunner B; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Krenner C; Metabolic Biochemistry, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Munich, Germany., Buschmann K; Metabolic Biochemistry, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Munich, Germany., Nuscher B; Metabolic Biochemistry, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Munich, Germany., Spieth L; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich (TUM), Munich, Germany., Junker N; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich (TUM), Munich, Germany., Berghoff SA; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich (TUM), Munich, Germany., Davis SS; Denali Therapeutics, Inc., South San Francisco, California, 94080, USA., Neher JJ; Metabolic Biochemistry, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Wurst W; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Institute of Developmental Genetics, Helmholtz Zentrum, Munich, Germany.; Technical University Munich (TUM), TUM Senior Excellence Faculty (SEF), Munich, Germany., Plesnila N; Institute for Stroke and Dementia Research,, University Hospital, Ludwig-Maximilians Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Lewcock JW; Denali Therapeutics, Inc., South San Francisco, California, 94080, USA., Simons M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Institute for Stroke and Dementia Research,, University Hospital, Ludwig-Maximilians Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich (TUM), Munich, Germany., Lichtenthaler SF; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine and Health, TUM University Hospital, Technical University of Munich (TUM), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Di Paolo G; Denali Therapeutics, Inc., South San Francisco, California, 94080, USA., Brendel M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Capell A; Metabolic Biochemistry, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Monroe KM; Denali Therapeutics, Inc., South San Francisco, California, 94080, USA. monroe@dnli.com., Schultze JL; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. joachim.schultze@dzne.de.; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany. joachim.schultze@dzne.de.; Platform for Single Cell Genomics and Epigenomics at the German Center for Neurodegenerative Diseases (DZNE), University of Bonn, Western German Genome Center (WGGC), Bonn, Germany. joachim.schultze@dzne.de., Haass C; Metabolic Biochemistry, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Munich, Germany. christian.haass@dzne.de.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. christian.haass@dzne.de.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. christian.haass@dzne.de. |
